Cholesterol-lowering drug Lipitor reduces mortality in study

08/29/2011 | CNN/The Chart blog

A follow-up study in the European Heart Journal found that patients taking Pfizer's cholesterol-lowering statin Lipitor had a 14% lower death rate compared with placebo users. The finding was attributed mainly to a significant reduction in mortality from respiratory and infectious diseases. A clinical trial of Lipitor ended in 2003 after the statin demonstrated effectiveness in preventing stroke and heart attack.

View Full Article in:

CNN/The Chart blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations